Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Sio Gene Therapies Inc. | siox-20210331.htm |
| EX-32.2 - EX-32.2 - Sio Gene Therapies Inc. | sioxex-322.htm |
| EX-32.1 - EX-32.1 - Sio Gene Therapies Inc. | sioxex-321.htm |
| EX-31.2 - EX-31.2 - Sio Gene Therapies Inc. | sioxex-312.htm |
| EX-31.1 - EX-31.1 - Sio Gene Therapies Inc. | sioxex-311.htm |
| EX-21.1 - EX-21.1 - Sio Gene Therapies Inc. | sioxex-211.htm |
| EX-10.16 - EX-10.16 - Sio Gene Therapies Inc. | sioxex-1016.htm |
| EX-4.3 - EX-4.3 - Sio Gene Therapies Inc. | sioxex-43.htm |
| EX-4.2 - EX-4.2 - Sio Gene Therapies Inc. | sioxex-42.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements of Sio Gene Therapies Inc.:
(1) Registration Statement (Form S-8 No. 333-206300) pertaining to the 2015 Equity Incentive Plan;
(2) Registration Statement (Form S-8 No. 333-215386) pertaining to the 2015 Equity Incentive Plan;
(3) Registration Statement (Form S-8 No. 333-220089) pertaining to the Amended and Restated 2015 Equity Incentive Plan;
(4) Registration Statement (Form S-8 No. 333-226877) pertaining to the Amended and Restated 2015 Equity Incentive Plan;
(5) Registration Statement (Form S-3 No. 333-235889);
(6) Registration Statement (Form S-8 No. 333-244371) pertaining to the Amended and Restated 2015 Equity Incentive Plan; and
(7) Registration Statement (Form S-4 No. 333-249279)
of our report dated June 9, 2021, with respect to the consolidated financial statements of Sio Gene Therapies Inc. included in this Annual Report (Form 10-K) of Sio Gene Therapies Inc. for the year ended March 31, 2021.
/s/ Ernst & Young LLP
Iselin, New Jersey
June 9, 2021
1